Abiopharma

News list

Shine Sarah 🟢 acquired 2.7K shares (1 derivative) of ERIE INDEMNITY CO (ERIE) at $242.04 Transaction Date: Jul 31, 2026 | Filing ID: 051639

Full text

News bot Aug. 3, 2026, 4:50 p.m.
🔍 Shine Sarah (Executive)

Company: ERIE INDEMNITY CO (ERIE)

Report Date: 2026-07-31
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 11
- Total shares held: 2,712
Detailed Transactions and Holdings:
- Acquired 11 shares of Class A Common Stock at $242.04 per share (Direct)
  Date: 2026-07-31 | Code: J | equity_swap_involved: 0 | shares_owned_after: 568.57 | transaction_form_type: 4 | Footnotes: F1
- Holds 2,712 shares of Incentive Compensation Deferral Plan Share Credits (Derivative)
  Date: 2026-07-31 | Code: H | shares_owned_after: 2,712.05 | Footnotes: F2, F3, F3
Footnotes:
- F1: Participant directed transaction under 401(k) Plan.
- F2: Conversion price is not applicable to shares granted under the Erie Indemnity Company Incentive Compensation Deferral Plan.
- F3: The shares subject to this reporting are Share Credits which are periodically credited to the accounts of a select group of management and highly compensated employees of Erie Indemnity Company pursuant to its Incentive Compensation Deferral Plan. These Share Credits represent the right to receive an equivalent number of shares of Erie Indemnity Company Class A common stock when the reporting individual retires or otherwise separates from service with the Company. There are no exercisable or expiration dates for these securities.